We are live on ! Find out more
EWTX icon

Edgewise Therapeutics
EWTX

31 hedge funds and large institutions have $1.48B invested in Edgewise Therapeutics in 2021 Q1 according to their latest regulatory filings, with 31 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

96.03% more ownership

Funds ownership: 0% → 96.03% (+96%)

Holders
31
Holders Change
+31
Holders Change %
–
% of All Funds
0.54%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.09%
New
31
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$452M
2
NHAS
Novo Holdings A/S
Denmark
+$181M
3
DM
Deerfield Management
New York
+$128M
4
Viking Global Investors
Viking Global Investors
Connecticut
+$109M
5
RCM
RA Capital Management
Massachusetts
+$84.8M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$453M +$452M +13,944,680 New
NHAS
2
Novo Holdings A/S
Denmark
$182M +$181M +5,587,207 New
DM
3
Deerfield Management
New York
$128M +$128M +3,933,137 New
Viking Global Investors
4
Viking Global Investors
Connecticut
$109M +$109M +3,352,249 New
RCM
5
RA Capital Management
Massachusetts
$84.9M +$84.8M +2,613,623 New
Citadel Advisors
6
Citadel Advisors
Florida
$77.4M +$77.2M +2,382,148 New
CAM
7
Cormorant Asset Management
Massachusetts
$74.3M +$75.9M +2,340,914 New
Janus Henderson Group
8
Janus Henderson Group
United Kingdom
$65.1M +$69.4M +2,140,908 New
NLVP
9
New Leaf Venture Partners
New York
$50.5M +$50.4M +1,553,661 New
Fidelity Investments
10
Fidelity Investments
Massachusetts
$49.7M +$49.6M +1,530,418 New
EC
11
EcoR1 Capital
California
$39.8M +$39.7M +1,224,175 New
LGM
12
Logos Global Management
California
$34.3M +$34.3M +1,056,812 New
Wellington Management Group
13
Wellington Management Group
Massachusetts
$23.1M +$24.1M +742,412 New
Federated Hermes
14
Federated Hermes
Pennsylvania
$20M +$20M +616,724 New
BBA
15
Baker Bros. Advisors
New York
$16.3M +$16.2M +500,000 New
Norges Bank
16
Norges Bank
Norway
$14.6M +$14.6M +449,000 New
WP
17
Woodline Partners
California
$11.6M +$11.6M +357,429 New
Adage Capital Partners
18
Adage Capital Partners
Massachusetts
$9.75M +$9.73M +300,000 New
American Century Companies
19
American Century Companies
Missouri
$9.05M +$9.03M +278,577 New
OCA
20
Octagon Capital Advisors
New York
$4.06M +$4.05M +125,000 New
Vanguard Group
21
Vanguard Group
Pennsylvania
$3.9M +$3.89M +120,000 New
SCM
22
Soleus Capital Management
Connecticut
$3.25M +$3.24M +100,000 New
SFM
23
Sphera Funds Management
Israel
$3.25M +$3.24M +100,000 New
CS
24
Credit Suisse
Switzerland
$2.73M +$2.73M +84,052 New
Goldman Sachs
25
Goldman Sachs
New York
$2.12M +$2.12M +65,263 New
1
2

EWTX Hedge Fund Activity: Q1 2021 in Review

31 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Edgewise Therapeutics (EWTX) for Q1 2021, worth a combined $1.48B.

Buyers outnumbered sellers: 31 funds opened new EWTX positions and 0 closed out — a net gain of 31 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was OrbiMed, opening a new position worth an estimated $452M.

  • 31 institutional investors held Edgewise Therapeutics (EWTX) as of Q1 2021, up from 0 in Q4 2020.
  • Funds reported $1.48B of Edgewise Therapeutics stock for Q1 2021.
  • 31 funds opened new Edgewise Therapeutics positions in Q1 2021 and 0 closed out, a net change of +31 holders.
  • The largest Edgewise Therapeutics buyer in Q1 2021 was OrbiMed, an estimated $452M added.

Based on aggregated 13F filings for Q1 2021.